Loracarbef

• Description:

  Loracarbef, a cephalosporin antibiotic, is an orally active second-generation synthetic beta-lactam antibiotic of the carbacephem class[1][2].

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H312-H332

• Target:

  Antibiotic; Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/loracarbef.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C(N12)=C(Cl)CC[C@]2([H])[C@H](NC([C@H](N)C3=CC=CC=C3)=O)C1=O)O

• Molecular Formula:

  C16H16ClN3O4

• Molecular Weight:

  349.77

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501

• References & Citations:

  [1]M Hu, et al. Mechanisms of Transport of Quinapril in Caco-2 Cell Monolayers: Comparison With Cephalexin. Pharm Res. 1995 Aug;12 (8) :1120-5.|[2]J W Dyke, et al. Antimicrobial Activity of New Antibiotics Against Bacterial Isolates From a Community Hospital. Chemotherapy. Sep-Oct 1993;39 (5) :315-21.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Launched

• Isoform:

  β-lactam

• CAS Number:

  [76470-66-1]